Literature DB >> 9205855

Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.

W G McCluggage1, P Maxwell, A Patterson, J M Sloan.   

Abstract

Inhibin is a peptide hormone produced by ovarian granulosa cells. During a recent study investigating the immunohistochemical staining of ovarian granulosa cell tumours and other neoplasms with an anti-inhibin monoclonal antibody, we identified strong cytoplasmic staining of hepatocytes. In the present study we investigated the immunostaining of hepatocellular carcinoma and other neoplasms involving the liver with anti-inhibin to determine whether the antibody may be of value in the differential diagnosis of hepatic neoplasms. Immunostaining for alpha-fetoprotein was also performed. With anti-inhibin there was positive, generally strong, cytoplasmic staining of 17 of 19 cases of hepatocellular carcinoma, including the pleomorphic and glandular variants. There was positive staining of six of 20 cases of adenocarcinoma. In these, positive staining was generally focal, of weak intensity and involved the luminal surface of neoplastic glands. There was no staining of five cases of neuroendocrine tumour. There was positive staining for alpha-fetoprotein in 13 of 19 cases of hepatocellular carcinoma and in two of 20 cases of adenocarcinoma but no staining of neuroendocrine tumours. Immunostaining with anti-inhibin antibody may be of value in the differentiation of hepatocellular carcinoma from other neoplasms involving the liver. The antibody is a more sensitive, but less specific, immunohistochemical marker for hepatocellular carcinoma than is alpha-fetoprotein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9205855     DOI: 10.1046/j.1365-2559.1997.5580774.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.

Authors:  W G McCluggage; J Burton; P Maxwell; J M Sloan
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

3.  Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis.

Authors:  Priyanka Singh; Laura M Jenkins; Ben Horst; Victoria Alers; Shrikant Pradhan; Prabhjot Kaur; Tapasya Srivastava; Nadine Hempel; Balázs Győrffy; Eugenia V Broude; Nam Y Lee; Karthikeyan Mythreye
Journal:  Cancer Res       Date:  2018-03-13       Impact factor: 12.701

Review 4.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

5.  Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers.

Authors:  Shrikant Pradhan; Roohi Chaudhary; Ben Horst; Eduardo Listik; Liz Quintero-Macias; Alex Seok Choi; Michael Southard; Yingmiao Liu; Regina Whitaker; Nadine Hempel; Andrew Berchuck; Andrew B Nixon; Nam Y Lee; Yoav I Henis; Karthikeyan Mythreye
Journal:  Commun Biol       Date:  2022-06-02

6.  Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?

Authors:  K Frost; K Seir; A Lackner; M Grusch; B Grasl-Kraupp; R Schulte-Hermann; C Rodgarkia-Dara
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

7.  An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.

Authors:  Shinya Kusumoto; Masako Kurashige; Kenji Ohshima; Shinichiro Tahara; Takahiro Matsui; Satoshi Nojima; Satoshi Hattori; Eiichi Morii
Journal:  Cancer Med       Date:  2021-02-20       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.